(3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: Potent and Selective Antagonists of the Serotonin 5-HT6 Receptor

5-HT6 receptors are exclusively localized in the CNS and have high affinity with many psychotropic agents. Though the role of this receptor in many CNS diseases is widely anticipated, lack of definite progress in the development of 5-HT6 receptor-oriented drugs indicates a need for further discoveri...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2010-07, Vol.53 (14), p.5186-5196
Hauptverfasser: Ivachtchenko, Alexandre V, Dmitriev, Dmitri E, Golovina, Elena S, Kadieva, Madina G, Koryakova, Angela G, Kysil, Volodymyr M, Mitkin, Oleg D, Okun, Ilya M, Tkachenko, Sergey E, Vorobiev, Anton A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 5196
container_issue 14
container_start_page 5186
container_title Journal of medicinal chemistry
container_volume 53
creator Ivachtchenko, Alexandre V
Dmitriev, Dmitri E
Golovina, Elena S
Kadieva, Madina G
Koryakova, Angela G
Kysil, Volodymyr M
Mitkin, Oleg D
Okun, Ilya M
Tkachenko, Sergey E
Vorobiev, Anton A
description 5-HT6 receptors are exclusively localized in the CNS and have high affinity with many psychotropic agents. Though the role of this receptor in many CNS diseases is widely anticipated, lack of definite progress in the development of 5-HT6 receptor-oriented drugs indicates a need for further discoveries of novel chemotypes with high potency and high selectivity to the receptor. Here we present preparations and biological evaluation of a series of (3-phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines. Phenylsulfonylcyclopentapyrazolopyrimidine 7 was found to be a highly selective 5-HT6 receptor antagonist with high affinity (low picomolar range) and potency. 7 and a few of its analogues were further tested for biological effect on 5-HT2B receptors and hERG potassium channels, potential liability targets. Such liability appears to be minimal, based on the in vitro data.
doi_str_mv 10.1021/jm100350r
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_748978914</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>748978914</sourcerecordid><originalsourceid>FETCH-LOGICAL-a240t-8028574e073ff26e25f8a5dd88048b1922b77b3898c467ab8fa99d5dcf8ace1d3</originalsourceid><addsrcrecordid>eNo9kctKxTAQhoMoerwsfAHpRlQwmqRNm7o7iDcQFC8rkZImU-0xTY5NKtRX8KWN19UwM98M88-P0CYlB5QwejjrKCEpJ_0CmlDOCM4EyRbRhBDGMMtZuoJWvZ-RCFGWLqMVRnhOeMkn6GM3xdfPYEfjB9O4GNWojJPmRVr3AIm0OtGP87GX7864B7rPsfxK267VrcUMj2ZPdq0Ff5RcuwA2fI_cggEV2jdIpjbIJ2dbH3zimiQ8Q2z2LsSSTTg-v8uTG1AwD65fR0uNNB42fuMauj89uTs-x5dXZxfH00ssWUYCFoQJXmRAirRpWA6MN0JyrUUULWpaMlYXRZ2KUqgsL2QtGlmWmmsVMQVUp2to52fvvHevA_hQda1XYIy04AZfFZkoC1HSLJJbv-RQd6CredQt-7H6-18Etn8AqXw1c0Nv4-EVJdWXL9W_L-kn-5x-TA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>748978914</pqid></control><display><type>article</type><title>(3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: Potent and Selective Antagonists of the Serotonin 5-HT6 Receptor</title><source>MEDLINE</source><source>American Chemical Society Publications</source><creator>Ivachtchenko, Alexandre V ; Dmitriev, Dmitri E ; Golovina, Elena S ; Kadieva, Madina G ; Koryakova, Angela G ; Kysil, Volodymyr M ; Mitkin, Oleg D ; Okun, Ilya M ; Tkachenko, Sergey E ; Vorobiev, Anton A</creator><creatorcontrib>Ivachtchenko, Alexandre V ; Dmitriev, Dmitri E ; Golovina, Elena S ; Kadieva, Madina G ; Koryakova, Angela G ; Kysil, Volodymyr M ; Mitkin, Oleg D ; Okun, Ilya M ; Tkachenko, Sergey E ; Vorobiev, Anton A</creatorcontrib><description>5-HT6 receptors are exclusively localized in the CNS and have high affinity with many psychotropic agents. Though the role of this receptor in many CNS diseases is widely anticipated, lack of definite progress in the development of 5-HT6 receptor-oriented drugs indicates a need for further discoveries of novel chemotypes with high potency and high selectivity to the receptor. Here we present preparations and biological evaluation of a series of (3-phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines. Phenylsulfonylcyclopentapyrazolopyrimidine 7 was found to be a highly selective 5-HT6 receptor antagonist with high affinity (low picomolar range) and potency. 7 and a few of its analogues were further tested for biological effect on 5-HT2B receptors and hERG potassium channels, potential liability targets. Such liability appears to be minimal, based on the in vitro data.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm100350r</identifier><identifier>PMID: 20560595</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Amines - chemical synthesis ; Amines - chemistry ; Amines - pharmacology ; Cell Line ; Crystallography, X-Ray ; ERG1 Potassium Channel ; Ether-A-Go-Go Potassium Channels - antagonists &amp; inhibitors ; Humans ; Models, Molecular ; Molecular Structure ; Pyrazoles - chemical synthesis ; Pyrazoles - chemistry ; Pyrazoles - pharmacology ; Pyrimidines - chemical synthesis ; Pyrimidines - chemistry ; Pyrimidines - pharmacology ; Radioligand Assay ; Receptors, Serotonin - metabolism ; Serotonin 5-HT2 Receptor Antagonists ; Serotonin Antagonists - chemical synthesis ; Serotonin Antagonists - chemistry ; Serotonin Antagonists - pharmacology ; Structure-Activity Relationship ; Sulfones - chemical synthesis ; Sulfones - chemistry ; Sulfones - pharmacology</subject><ispartof>Journal of medicinal chemistry, 2010-07, Vol.53 (14), p.5186-5196</ispartof><rights>Copyright © 2010 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm100350r$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm100350r$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>315,782,786,27083,27931,27932,56745,56795</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20560595$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ivachtchenko, Alexandre V</creatorcontrib><creatorcontrib>Dmitriev, Dmitri E</creatorcontrib><creatorcontrib>Golovina, Elena S</creatorcontrib><creatorcontrib>Kadieva, Madina G</creatorcontrib><creatorcontrib>Koryakova, Angela G</creatorcontrib><creatorcontrib>Kysil, Volodymyr M</creatorcontrib><creatorcontrib>Mitkin, Oleg D</creatorcontrib><creatorcontrib>Okun, Ilya M</creatorcontrib><creatorcontrib>Tkachenko, Sergey E</creatorcontrib><creatorcontrib>Vorobiev, Anton A</creatorcontrib><title>(3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: Potent and Selective Antagonists of the Serotonin 5-HT6 Receptor</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>5-HT6 receptors are exclusively localized in the CNS and have high affinity with many psychotropic agents. Though the role of this receptor in many CNS diseases is widely anticipated, lack of definite progress in the development of 5-HT6 receptor-oriented drugs indicates a need for further discoveries of novel chemotypes with high potency and high selectivity to the receptor. Here we present preparations and biological evaluation of a series of (3-phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines. Phenylsulfonylcyclopentapyrazolopyrimidine 7 was found to be a highly selective 5-HT6 receptor antagonist with high affinity (low picomolar range) and potency. 7 and a few of its analogues were further tested for biological effect on 5-HT2B receptors and hERG potassium channels, potential liability targets. Such liability appears to be minimal, based on the in vitro data.</description><subject>Amines - chemical synthesis</subject><subject>Amines - chemistry</subject><subject>Amines - pharmacology</subject><subject>Cell Line</subject><subject>Crystallography, X-Ray</subject><subject>ERG1 Potassium Channel</subject><subject>Ether-A-Go-Go Potassium Channels - antagonists &amp; inhibitors</subject><subject>Humans</subject><subject>Models, Molecular</subject><subject>Molecular Structure</subject><subject>Pyrazoles - chemical synthesis</subject><subject>Pyrazoles - chemistry</subject><subject>Pyrazoles - pharmacology</subject><subject>Pyrimidines - chemical synthesis</subject><subject>Pyrimidines - chemistry</subject><subject>Pyrimidines - pharmacology</subject><subject>Radioligand Assay</subject><subject>Receptors, Serotonin - metabolism</subject><subject>Serotonin 5-HT2 Receptor Antagonists</subject><subject>Serotonin Antagonists - chemical synthesis</subject><subject>Serotonin Antagonists - chemistry</subject><subject>Serotonin Antagonists - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>Sulfones - chemical synthesis</subject><subject>Sulfones - chemistry</subject><subject>Sulfones - pharmacology</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kctKxTAQhoMoerwsfAHpRlQwmqRNm7o7iDcQFC8rkZImU-0xTY5NKtRX8KWN19UwM98M88-P0CYlB5QwejjrKCEpJ_0CmlDOCM4EyRbRhBDGMMtZuoJWvZ-RCFGWLqMVRnhOeMkn6GM3xdfPYEfjB9O4GNWojJPmRVr3AIm0OtGP87GX7864B7rPsfxK267VrcUMj2ZPdq0Ff5RcuwA2fI_cggEV2jdIpjbIJ2dbH3zimiQ8Q2z2LsSSTTg-v8uTG1AwD65fR0uNNB42fuMauj89uTs-x5dXZxfH00ssWUYCFoQJXmRAirRpWA6MN0JyrUUULWpaMlYXRZ2KUqgsL2QtGlmWmmsVMQVUp2to52fvvHevA_hQda1XYIy04AZfFZkoC1HSLJJbv-RQd6CredQt-7H6-18Etn8AqXw1c0Nv4-EVJdWXL9W_L-kn-5x-TA</recordid><startdate>20100722</startdate><enddate>20100722</enddate><creator>Ivachtchenko, Alexandre V</creator><creator>Dmitriev, Dmitri E</creator><creator>Golovina, Elena S</creator><creator>Kadieva, Madina G</creator><creator>Koryakova, Angela G</creator><creator>Kysil, Volodymyr M</creator><creator>Mitkin, Oleg D</creator><creator>Okun, Ilya M</creator><creator>Tkachenko, Sergey E</creator><creator>Vorobiev, Anton A</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>20100722</creationdate><title>(3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: Potent and Selective Antagonists of the Serotonin 5-HT6 Receptor</title><author>Ivachtchenko, Alexandre V ; Dmitriev, Dmitri E ; Golovina, Elena S ; Kadieva, Madina G ; Koryakova, Angela G ; Kysil, Volodymyr M ; Mitkin, Oleg D ; Okun, Ilya M ; Tkachenko, Sergey E ; Vorobiev, Anton A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a240t-8028574e073ff26e25f8a5dd88048b1922b77b3898c467ab8fa99d5dcf8ace1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Amines - chemical synthesis</topic><topic>Amines - chemistry</topic><topic>Amines - pharmacology</topic><topic>Cell Line</topic><topic>Crystallography, X-Ray</topic><topic>ERG1 Potassium Channel</topic><topic>Ether-A-Go-Go Potassium Channels - antagonists &amp; inhibitors</topic><topic>Humans</topic><topic>Models, Molecular</topic><topic>Molecular Structure</topic><topic>Pyrazoles - chemical synthesis</topic><topic>Pyrazoles - chemistry</topic><topic>Pyrazoles - pharmacology</topic><topic>Pyrimidines - chemical synthesis</topic><topic>Pyrimidines - chemistry</topic><topic>Pyrimidines - pharmacology</topic><topic>Radioligand Assay</topic><topic>Receptors, Serotonin - metabolism</topic><topic>Serotonin 5-HT2 Receptor Antagonists</topic><topic>Serotonin Antagonists - chemical synthesis</topic><topic>Serotonin Antagonists - chemistry</topic><topic>Serotonin Antagonists - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>Sulfones - chemical synthesis</topic><topic>Sulfones - chemistry</topic><topic>Sulfones - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ivachtchenko, Alexandre V</creatorcontrib><creatorcontrib>Dmitriev, Dmitri E</creatorcontrib><creatorcontrib>Golovina, Elena S</creatorcontrib><creatorcontrib>Kadieva, Madina G</creatorcontrib><creatorcontrib>Koryakova, Angela G</creatorcontrib><creatorcontrib>Kysil, Volodymyr M</creatorcontrib><creatorcontrib>Mitkin, Oleg D</creatorcontrib><creatorcontrib>Okun, Ilya M</creatorcontrib><creatorcontrib>Tkachenko, Sergey E</creatorcontrib><creatorcontrib>Vorobiev, Anton A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ivachtchenko, Alexandre V</au><au>Dmitriev, Dmitri E</au><au>Golovina, Elena S</au><au>Kadieva, Madina G</au><au>Koryakova, Angela G</au><au>Kysil, Volodymyr M</au><au>Mitkin, Oleg D</au><au>Okun, Ilya M</au><au>Tkachenko, Sergey E</au><au>Vorobiev, Anton A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>(3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: Potent and Selective Antagonists of the Serotonin 5-HT6 Receptor</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2010-07-22</date><risdate>2010</risdate><volume>53</volume><issue>14</issue><spage>5186</spage><epage>5196</epage><pages>5186-5196</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>5-HT6 receptors are exclusively localized in the CNS and have high affinity with many psychotropic agents. Though the role of this receptor in many CNS diseases is widely anticipated, lack of definite progress in the development of 5-HT6 receptor-oriented drugs indicates a need for further discoveries of novel chemotypes with high potency and high selectivity to the receptor. Here we present preparations and biological evaluation of a series of (3-phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines. Phenylsulfonylcyclopentapyrazolopyrimidine 7 was found to be a highly selective 5-HT6 receptor antagonist with high affinity (low picomolar range) and potency. 7 and a few of its analogues were further tested for biological effect on 5-HT2B receptors and hERG potassium channels, potential liability targets. Such liability appears to be minimal, based on the in vitro data.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>20560595</pmid><doi>10.1021/jm100350r</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2010-07, Vol.53 (14), p.5186-5196
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_748978914
source MEDLINE; American Chemical Society Publications
subjects Amines - chemical synthesis
Amines - chemistry
Amines - pharmacology
Cell Line
Crystallography, X-Ray
ERG1 Potassium Channel
Ether-A-Go-Go Potassium Channels - antagonists & inhibitors
Humans
Models, Molecular
Molecular Structure
Pyrazoles - chemical synthesis
Pyrazoles - chemistry
Pyrazoles - pharmacology
Pyrimidines - chemical synthesis
Pyrimidines - chemistry
Pyrimidines - pharmacology
Radioligand Assay
Receptors, Serotonin - metabolism
Serotonin 5-HT2 Receptor Antagonists
Serotonin Antagonists - chemical synthesis
Serotonin Antagonists - chemistry
Serotonin Antagonists - pharmacology
Structure-Activity Relationship
Sulfones - chemical synthesis
Sulfones - chemistry
Sulfones - pharmacology
title (3-Phenylsulfonylcycloalkano[e and d]pyrazolo[1,5-a]pyrimidin-2-yl)amines: Potent and Selective Antagonists of the Serotonin 5-HT6 Receptor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-06T14%3A06%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=(3-Phenylsulfonylcycloalkano%5Be%20and%20d%5Dpyrazolo%5B1,5-a%5Dpyrimidin-2-yl)amines:%20Potent%20and%20Selective%20Antagonists%20of%20the%20Serotonin%205-HT6%20Receptor&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Ivachtchenko,%20Alexandre%20V&rft.date=2010-07-22&rft.volume=53&rft.issue=14&rft.spage=5186&rft.epage=5196&rft.pages=5186-5196&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm100350r&rft_dat=%3Cproquest_pubme%3E748978914%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=748978914&rft_id=info:pmid/20560595&rfr_iscdi=true